Home - Category

  • All Post
  • Fact Sheets
  • Feature
  • Frequently Asked Questions
  • Headlines
  • Testing
  • Treatment
  • Uncategorized

February 20, 2007/

Summary: The FDA changed the FUZEON prescribing information to help avoid this common and unpleasant side effect of the drug. —————————————- On January 31 the FDA announced that the FUZEON (enfuvirtide) package insert had been changed to include precautions to avoid injection-site reactions, either using a needle, or the Biojector(r)…

© 2023 Aids.org